Risk of liver disease in HCV-seropositive kidney transplant recipients.

OBJECTIVE: This study determined whether renal allograft recipients with antibodies to hepatitis C virus (HCV) at the time of transplantation experienced increased morbidity or mortality from hepatitis, liver disease, or hepatocellular carcinoma compared with patients without anti-HCV. SUMMARY BACKG...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Rohr, M S, Lesniewski, R R, Rubin, C A, Johnson, R G, Heise, E R, McDonald, J C, Adams, P L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1993
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1242833/
https://ncbi.nlm.nih.gov/pubmed/8387764
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia